Table 2.
Overall Mortality | CRC Mortality | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
SMD Range |
At-risk | Events | HR | Lower bound, 95% CI |
Upper bound, 95% CI |
Events | HR | Lower bound, 95% CI |
Upper bound, 95% CI |
|
Low SMD by sex-specific optimal stratification | 879 | 451 | ||||||||
Normal | 32.5 – 72.1 | 2296 | 481 | 259 | ||||||
Low | 5.7 – 35.5 | 966 | 398 | 1.61 | 1.36 | 1.90 | 192 | 1.74 | 1.38 | 2.21 |
Quartiles of SMD | ||||||||||
High | 44.4 – 72.1 | 815 | 153 | 93 | ||||||
Mid-High | 37.7 – 47.2 | 816 | 177 | 0.94 | 0.75 | 1.18 | 89 | 0.94 | 0.68 | 1.28 |
Mid-Low | 30.8 – 41.0 | 816 | 201 | 0.95 | 0.75 | 1.21 | 109 | 1.10 | 0.79 | 1.53 |
Low | 5.7 – 34.6 | 815 | 348 | 1.50 | 1.15 | 1.94 | 160 | 1.63 | 1.13 | 2.36 |
p for trend across quartiles | 0.001 | 0.003 | ||||||||
p for trend (continuous) | <0.0001 | 0.0001 |
"SMD"=skeletal muscle radiodensity (HU); HR=hazard ratio
Models simultaneously adjusted for muscle mass, visceral and subcutaneous adiposity in quartiles
Additionally adjusted for age at diagnosis (continuous), sex (ref=Male), race (ref=White), site (ref=Proximal), stage (ref=I), grade (ref=Well differentiated), chemotherapy (ref=No), radiation (ref=No), smoking history (ref=Never), comorbidity score (ref=0) and partitioned BMI (continuous)